Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma

Rationale: Hemangioma of the liver is a benign hepatic tumor, more common in women than in men, which is typically asymptomatic, solitary, and incidentally discovered. Atypical hemangioma is a variant of hepatic hemangioma with atypical imaging finding features on CT and MRI that can be confused with hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and mixed hepatocellular cholangiocarcinoma (HCC-CC). Patient concerns: We report a case of atypical hepatic hemangioma mimicking HCC-CC: A 59-year-old man was referred to our hospital for a hepatic lesion that was 4.7×3.6 cm in size and located in segments 2 and 3 of the liver. Serum alpha-fetoprotein (AFP) level increased from 17.03 ng/mL to 374.9 ng/mL. The patient was positive for hepatitis B. Diagnoses: Atypical hepatic hemangioma. Interventions: US, CT, MRI and Tc-99m RBC liver scans were performed. Dynamic contrast-enhanced MRI showed no uptake in the corresponding area during the arterial phase, peripheral nodular enhancement during the portal phase and delayed phase, and hypo-intensity in the central area. An initial diagnosis of HCC-CC was offered based on the history and imaging findings. Finally, percutaneous liver biopsy (PLB) was offered to the patient. Histopathologic examination of the liver lesions revealed nodular cirrhosis and atypical hyperplasia of liver cells with cavernous hemangioma, where numerous old Schistosoma japonicum eggs were found. Outcomes: Accurate diagnosis of the patient obviated the need for surgery. The patient's recovery after liver puncture was uneventful, and he was discharged on the seventh post-operative day. Lessons: In some cases, accurate preoperative imaging of focal hepatic lesions is essential but insufficient for diagnosis. PLB and histopathological examination are important, especially in patients with suspected malignancy.

[1]  G. Brandi,et al.  Cholangiocarcinoma : Current opinion on clinical practice diagnostic and therapeutic algorithms , 2015 .

[2]  Kathryn J Fowler,et al.  Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma , 2014, Abdominal Imaging.

[3]  Ji Soo Song,et al.  A sclerosing hemangioma of the liver , 2013, Clinical and molecular hepatology.

[4]  D. Da Inès,et al.  Hepatic haemangioma: common and uncommon imaging features. , 2013, Diagnostic and interventional imaging.

[5]  Ying Zhou,et al.  Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and Prognosis , 2012, Annals of Surgical Oncology.

[6]  B. van Hoek,et al.  Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy? , 2011, Gastroenterology research and practice.

[7]  M. Nguyen,et al.  The diagnosis and management of benign hepatic tumors. , 2005, Journal of clinical gastroenterology.

[8]  D. Podoloff,et al.  Radioimmunoscintigraphy in the differential diagnosis of hepatic mass lesion , 1995, European Journal of Nuclear Medicine.

[9]  J. Numminen,et al.  Magnetic Resonance Imaging of the Liver: True Fast Imaging with Steady State Free Precession Sequence Facilitates Rapid and Reliable Distinction Between Hepatic Hemangiomas and Liver Malignancies , 2003, Journal of computer assisted tomography.

[10]  S. Fan,et al.  Hepatic resection for combined hepatocellular and cholangiocarcinoma. , 2003, Archives of surgery.

[11]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[12]  B. Kim,et al.  Sclerosis of hepatic cavernous hemangioma: CT findings and pathologic correlation. , 1995, Journal of Korean medical science.